How minocycline affects blood pressure in resistant hypertension
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis
This study is looking at how the antibiotic minocycline might help people with stubborn high blood pressure by exploring how our gut bacteria, brain, and immune system work together, and it aims to find better ways to manage this condition, especially for those who don't respond well to usual treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11040333 on NIH RePORTER |
What this research studies
This research investigates the effects of minocycline, an antibiotic with anti-inflammatory properties, on patients with resistant hypertension, a condition where blood pressure remains high despite treatment. The study focuses on understanding the role of the gut microbiota and its connection to the brain and immune system in influencing blood pressure. By exploring these mechanisms, the research aims to identify new strategies for managing hypertension, particularly in populations that experience disparities in treatment outcomes. Patients will be monitored for changes in blood pressure and related health markers throughout the study.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with resistant hypertension who require multiple antihypertensive medications to manage their condition.
Not a fit: Patients with well-controlled hypertension or those who do not meet the criteria for resistant hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for patients with resistant hypertension, improving their blood pressure control and overall cardiovascular health.
How similar studies have performed: Previous research has shown promising results with minocycline in animal models and some human studies, suggesting that this approach may be effective, although it is still being explored in the context of resistant hypertension.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Smith, Steven Michael — University of Florida
- Study coordinator: Smith, Steven Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.